Determining the Special Gene Expressions in Patients with Lung Cancer or Mesothelioma

Overview

About this study

This study is being done to evaluate the immune system in patients with lung cancer or mesothelioma. We are going to analyze which genes are expressed by cells that fight infections to see if there are any relations to cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Subject population: 

Patients with metastatic adenocarcinoma of the lung or mesothelioma

Inclusion Criteria:

  • Have a diagnosis of non-small cell carcinoma of the lung or mesothelioma

  • Willing to provide blood sample

Exclusion Criteria: 

  • Non-thoracic malignancy

  • Unwilling to participate

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Aaron Mansfield, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20312412

Mayo Clinic Footer